We are live on ! Find out more
SEM

Select Medical

Delisted

SEM was delisted on the 30th of June, 2026.

251 hedge funds and large institutions have $3B invested in Select Medical in 2024 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 87 increasing their positions, 90 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more capital invested

Capital invested by funds: $2.34B → $3B (+$663M)

19% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 31

1% more funds holding

Funds holding: 249251 (+2)

0.36% less ownership

Funds ownership: 144%143.65% (-0.36%)

3% less repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 90

52% less call options, than puts

Call options by funds: $187K | Put options by funds: $389K

Holders
251
Holders Change
+2
Holders Change %
+0.8%
% of All Funds
3.61%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
37
Increased
87
Reduced
90
Closed
31
Calls
$187K
Puts
$389K
Net Calls
-$202K
Net Calls Change
+$29K
Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$519M +$2.46M +168,161 +0.5%
BlackRock
2
BlackRock
New York
$497M -$9.69M -662,085 -2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$392M +$17.7M +1,206,573 +5%
T. Rowe Price Investment Management
4
T. Rowe Price Investment Management
Maryland
$171M -$8.19M -559,343 -5%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$133M -$774K -52,872 -0.6%
State Street
6
State Street
Massachusetts
$125M -$686K -46,875 -0.6%
CCM
7
Camber Capital Management
Massachusetts
$103M
Geode Capital Management
8
Geode Capital Management
Massachusetts
$68.2M +$1.78M +121,603 +3%
Principal Financial Group
9
Principal Financial Group
Iowa
$67.6M +$2.6M +177,632 +4%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$56M -$1.33M -90,647 -3%
8KM
11
8 Knots Management
Texas
$49.8M +$38.6M +2,637,484 New
Invesco
12
Invesco
Georgia
$47.9M -$2.57M -175,277 -6%
Charles Schwab
13
Charles Schwab
California
$46.9M +$2.41M +164,546 +6%
Victory Capital Management
14
Victory Capital Management
Texas
$44.6M -$7.1M -484,795 -15%
Norges Bank
15
Norges Bank
Norway
$41.2M -$2.54M -173,334 -6%
Nuveen
16
Nuveen
North Carolina
$38.2M +$5.74M +391,897 +20%
Northern Trust
17
Northern Trust
Illinois
$36.4M -$879K -60,049 -3%
Morgan Stanley
18
Morgan Stanley
New York
$34M -$42.5M -2,901,983 -58%
Bank of America
19
Bank of America
North Carolina
$31M +$3.37M +230,229 +14%
LSV Asset Management
20
LSV Asset Management
Illinois
$24.2M -$18.7M -1,279,368 -46%
Arrowstreet Capital
21
Arrowstreet Capital
Massachusetts
$22.8M +$3.21M +219,095 +19%
VOYA Investment Management
22
VOYA Investment Management
Georgia
$21.7M +$15.9M +1,089,452 +446%
Goldman Sachs
23
Goldman Sachs
New York
$17.2M +$2.54M +173,768 +20%
JP Morgan Chase
24
JP Morgan Chase
New York
$11.7M +$1.01M +69,128 +11%
DIA
25
Dana Investment Advisors
Wisconsin
$11.3M +$10.2M +696,548 New

SEM Hedge Fund Activity: Q1 2024 in Review

251 of the 6,948 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q1 2024, worth a combined $3B — up 28% from $2.34B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new SEM positions and 31 closed out — a net gain of 6 holders — while 87 added to existing stakes and 90 trimmed.

The largest buyer was 8 Knots Management, opening a new position worth an estimated $38.6M. The largest seller was Morgan Stanley, cutting an estimated $42.5M.

  • 251 institutional investors held Select Medical (SEM) as of Q1 2024, up from 249 in Q4 2023.
  • Funds reported $3B of Select Medical stock for Q1 2024, up 28% quarter-over-quarter.
  • 37 funds opened new Select Medical positions in Q1 2024 and 31 closed out, a net change of +6 holders.
  • The largest Select Medical buyer in Q1 2024 was 8 Knots Management, an estimated $38.6M added.
  • The largest Select Medical seller in Q1 2024 was Morgan Stanley, an estimated $42.5M sold.

Based on aggregated 13F filings for Q1 2024.